[1]
2022. Cost-Effectiveness Analysis of Budesonide/Formoterol and Fluticasone/Salmeterol for Stable Chronic Obstructive Lung Disease. Jurnal Respirologi Indonesia. 42, 4 (Oct. 2022), 289–297. DOI:https://doi.org/10.36497/jri.v42i4.378.